A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Keryx Biopharmaceuticals

About Keryx

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of serious, life-threatening diseases, including diabetes and cancer.



Pipeline for KERYX



Sulodexide or KRX-101, for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes, and

Perifosine or KRX-0401, for the treatment of multiple forms of cancer. Keryx announced that it has acquired ACCESS Oncology, Inc. and its subsidiaries or ACCESS Oncology, a cancer-focused biotechnology company. The acquired drug portfolio includes three clinical stage compounds, designated as

KRX-0402 --inhibitor of DNA repair

KRX-0403. --a novel spindle poison in the same general class as Navelbine®, Taxol® and Taxotere®


More on Keryx


Home Page

Key Statistics for Keryx

Basic Chart for Keryx

Analyst Opinion

Analysts Estimates



Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.